{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:53:22Z","timestamp":1780610002452,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Schistosomiasis is a neglected tropical disease caused by parasitic flatworms of the genus <jats:italic>Schistosoma<\/jats:italic>. Currently, praziquantel is the only medication available for treating schistosomiasis. However, crucial issues regarding drug resistance, reinfection, and prevention remain unresolved. Therefore, it is indispensable to develop new antischistosomal drugs, whose mechanisms of action are distinct from that of praziquantel. This diversification in treatment is vital to promote the eradication of schistosomiasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this study, to explore the untapped antischistosomal compounds against <jats:italic>Schistosoma<\/jats:italic> species, which have diverse life cycles, we initially investigated the effects of a series of phenanthroline-based compounds (PHN-<jats:italic>X<\/jats:italic>) with iron-binding affinity on the survival capacity of <jats:italic>Schistosoma mansoni<\/jats:italic> larvae and egg production by paired adult worms in vitro. Subsequently, we examined the impacts of PHN-<jats:italic>X<\/jats:italic> on the egg production and fecundity of female adult worms in vivo, following oral administration of them to mice infected with <jats:italic>S. mansoni<\/jats:italic> cercariae. Finally, we conducted a morphological analysis of the reproductive organs of the female adult worms after treating <jats:italic>S. mansoni<\/jats:italic>-infected mice with a newly identified compound with high anti-fecundity effect.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The assay for determining IC<jats:sub>50<\/jats:sub> and IC<jats:sub>90<\/jats:sub> values against schistosomula indicated that PHN-<jats:italic>X<\/jats:italic> effectively led to larval death, unlike deferoxamine and praziquantel. The larvicidal activity depended on the strength of the coordination bonds between its nitrogen atoms and an iron ion. Furthermore, PHN-<jats:italic>X<\/jats:italic> with electron-donating groups substantially inhibited the egg-laying behavior of paired adult worms in vitro. Notably, orally administrating PHN-(OMe)<jats:sub>2<\/jats:sub> with two methoxy groups to <jats:italic>S. mansoni<\/jats:italic>-infected mice decreased the egg production rate of the female adult worms. The analyses of the ovarian area and the reaction of PHN-(OMe)<jats:sub>2<\/jats:sub> with iron ions indicated that containment of Fe(II) ions caused abnormal ovarian atrophy, contributing to the expression of its anti-fecundity effect in vivo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>PHN-(OMe)<jats:sub>2<\/jats:sub>, which has an affinity for Fe(II) ion-binding affinity, significantly affected the survival of larvae and egg-laying behavior of female adult worms. Thus, the strategy for containing the iron source required by <jats:italic>S. mansoni<\/jats:italic> could offer valuable insight for developing new drugs to diversify the treatment options for schistosomiasis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41182-025-00800-x","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T02:52:25Z","timestamp":1756781545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular containment of iron source inhibits larval survival of Schistosoma mansoni and egg-laying behavior of the female adult worms via ovarian atrophy"],"prefix":"10.1186","volume":"53","author":[{"given":"Takashi","family":"Kumagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Shimogawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"800_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou X-N. Schistosomiasis. Nat Rev Dis Primers. 2018;4:13.","journal-title":"Nat Rev Dis Primers"},{"key":"800_CR2","first-page":"629","volume":"95","author":"World Health Organization (WHO)","year":"2020","unstructured":"World Health Organization (WHO). Schistosomiasis and soil-transmitted helminthiases: numbers of people treated in 2019. Wkly Epidemiol Rec. 2020;95:629\u201340.","journal-title":"Wkly Epidemiol Rec"},{"key":"800_CR3","unstructured":"WHO. Ending the neglect to attain the sustainable development goals: a global strategy on water sanitation and hygiene to combat neglected tropical diseases 2021\u22122030. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. https:\/\/iris.who.int\/handle\/10665\/340240."},{"key":"800_CR4","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1473-3099(22)00221-3","volume":"22","author":"NC Lo","year":"2022","unstructured":"Lo NC, Bezerra FSM, Colley DG, Fleming FM, Homeida M, Kabatereine N, et al. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. Lancet Infect Dis. 2022;22:e327\u201335.","journal-title":"Lancet Infect Dis"},{"key":"800_CR5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijid.2016.09.023","volume":"54","author":"AGP Ross","year":"2017","unstructured":"Ross AGP, Chau TN, Inobaya MY, Olveda RM, Li Y, Harn DA. A new global strategy for the elimination of schistosomiasis. Int J Infect Dis. 2017;54:130\u20137.","journal-title":"Int J Infect Dis"},{"key":"800_CR6","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1021\/acsinfecdis.3c00081","volume":"9","author":"N Caldwell","year":"2023","unstructured":"Caldwell N, Afshar R, Baraga\u00f1a B, Bustinduy AL, Caffrey CR, Collins JJ, et al. Perspective on schistosomiasis drug discovery: highlights from a schistosomiasis drug discovery workshop at Wellcome Collection London September 2022. ACS Infect Dis. 2023;9:1046\u201355.","journal-title":"ACS Infect Dis"},{"key":"800_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijpddr.2021.05.002","volume":"16","author":"PT LoVerde","year":"2021","unstructured":"LoVerde PT, Alwan SN, Taylor AB, Rhodes J, Chevalier FD, Anderson TJ, et al. Rational approach to drug discovery for human schistosomiasis. Int J Parasitol Drugs Drug Resist. 2021;16:140\u20137.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"800_CR8","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1016\/S2666-5247(23)00377-4","volume":"5","author":"MT Vaillant","year":"2024","unstructured":"Vaillant MT, Philippy F, Neven A, Barr\u00e9 J, Bulaev D, Olliaro PL, et al. Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis. Lancet Microbe. 2024;5:e366\u201378.","journal-title":"Lancet Microbe"},{"key":"800_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126822","volume":"10","author":"J Wang","year":"2015","unstructured":"Wang J, Wang S, Liu X, Xu B, Chai R, Zhou P, et al. Intake of erythrocytes required for reproductive development of female Schistosoma japonicum. PLoS ONE. 2015;10:e0126822.","journal-title":"PLoS ONE"},{"key":"800_CR10","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1111\/febs.13368","volume":"282","author":"SQ Toh","year":"2015","unstructured":"Toh SQ, Gobert GN, Malag\u00f3n Mart\u00ednez D, Jones MK. Haem uptake is essential for egg production in the haematophagous blood fluke of humans Schistosoma mansoni. FEBS J. 2015;282:3632\u201346.","journal-title":"FEBS J"},{"key":"800_CR11","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253\u201364.","journal-title":"Lancet"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.ijpara.2005.05.002","volume":"35","author":"S Botros","year":"2005","unstructured":"Botros S, Pica-Mattoccia L, William S, El-Lakkani N, Cioli D. Effect of praziquantel on the immature stages of Schistosoma haematobium. Int J Parasitol. 2005;35:1453\u20137.","journal-title":"Int J Parasitol"},{"key":"800_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.phrs.2016.02.017","volume":"110","author":"MEM Saeed","year":"2016","unstructured":"Saeed MEM, Krishna S, Greten HJ, Kremsner PG, Efferth T. Antischistosomal activity of artemisinin derivatives in vivo and in patients. Pharmacol Res. 2016;110:216\u201326.","journal-title":"Pharmacol Res"},{"key":"800_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1756-3305-4-201","volume":"4","author":"R Liu","year":"2011","unstructured":"Liu R, Dong H-F, Guo Y, Zhao Q-P, Jiang M-S. Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasit Vectors. 2011;4:201.","journal-title":"Parasit Vectors"},{"key":"800_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.pt.2007.08.018","volume":"23","author":"A Glanfield","year":"2007","unstructured":"Glanfield A, McManus DP, Anderson GJ, Jones MK. Pumping iron: a potential target for novel therapeutics against schistosomes. Trends Parasitol. 2007;23:583\u20138.","journal-title":"Trends Parasitol"},{"key":"800_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.biopha.2018.10.036","volume":"109","author":"NH Abdelgelil","year":"2019","unstructured":"Abdelgelil NH, Abdellatif MZM, Abdel-Hafeez EH, Belal US, Mohamed RM, Abdel-Razik A-RH, et al. Effects of iron chelating agent on Schistosoma mansoni infected murine model. Biomed Pharmacother. 2019;109:28\u201338.","journal-title":"Biomed Pharmacother"},{"key":"800_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1021\/acsinfecdis.1c00418","volume":"8","author":"A Wada","year":"2022","unstructured":"Wada A, Umeki Y, Annoura T, Saito-Nakano Y. In vitro and in vivo antiamebic activity of iron-targeting polypyridine compounds against enteric protozoan parasite Entamoeba histolytica. ACS Infect Dis. 2022;8:457\u201362.","journal-title":"ACS Infect Dis"},{"key":"800_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2022.102540","volume":"87","author":"T Kumagai","year":"2022","unstructured":"Kumagai T, Shimogawara R, Ichimura K, Iwanaga S. Calpain inhibitor suppresses both extracellular vesicle-mediated secretion of miRNAs and egg production from paired adults of Schistosoma japonicum. Parasitol Int. 2022;87:102540.","journal-title":"Parasitol Int"},{"key":"800_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s41182-025-00727-3","volume":"53","author":"T Kumagai","year":"2025","unstructured":"Kumagai T, Miyamoto M, Koseki Y, Imai Y, Ishino T. Development of a spirulina feed effective only for the two larval stages of Schistosoma mansoni, not the intermediate host mollusc. Trop Med Health. 2025;53:46.","journal-title":"Trop Med Health"},{"key":"800_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.parint.2016.10.013","volume":"66","author":"M Yamabe","year":"2017","unstructured":"Yamabe M, Kumagai T, Shimogawara R, Blay EA, Hino A, Ichimura K, et al. Novel synthetic compounds with endoperoxide structure damage juvenile stage of Schistosoma mansoni by targeting lysosome-like organelles. Parasitol Int. 2017;66:917\u201324.","journal-title":"Parasitol Int"},{"key":"800_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41596-018-0101-y","volume":"14","author":"FC Lombardo","year":"2019","unstructured":"Lombardo FC, Pasche V, Panic G, Endriss Y, Keiser J. Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni. Nat Protoc. 2019;14:461\u201381.","journal-title":"Nat Protoc"},{"key":"800_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1021\/acsinfecdis.4c00846","volume":"11","author":"A Wada","year":"2025","unstructured":"Wada A, Asahi H. Identification of a class of iron-grabbing compounds with antiplasmodial activity: impact of coordination structures and electronic regularity on the intraerythrocytic growth cycle of Plasmodium falciparum. ACS Infect Dis. 2025;11:799\u2013804.","journal-title":"ACS Infect Dis"},{"key":"800_CR23","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1128\/AAC.02741-14","volume":"58","author":"I Meister","year":"2014","unstructured":"Meister I, Ingram-Sieber K, Cowan N, Todd M, Robertson MN, Meli C, et al. Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni. Antimicrob Agents Chemother. 2014;58:5466\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"800_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1017\/S0031182097002370","volume":"116","author":"TA Day","year":"1998","unstructured":"Day TA, Chen GZ. The metalloprotease inhibitor 1,10-phenanthroline affects Schistosoma mansoni motor activity, egg laying and viability. Parasitology. 1998;116:319\u201325.","journal-title":"Parasitology"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00800-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00800-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:16:11Z","timestamp":1757477771000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00800-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00800-x","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}